Sangamo Therapeutics, Inc. (SGMO) Ownership

$0.61

south_east
-$0.05 (-7.63%)
Day's range
$0.53
Day's range
$0.62

Sangamo Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 02/11/2025 9.37 M $9.56 M   -2.32% 4.50%
WASATCH ADVISORS LP 02/13/2025 9.23 M $9.42 M   -52.52% 4.43%
BLACKROCK, INC. 02/07/2025 5.19 M $5.30 M   43.10% 2.49%
STATE STREET CORP 02/14/2025 5.02 M $5.12 M   655.17% 2.41%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 3.08 M $3.15 M   -36.43% 1.48%
MILLENNIUM MANAGEMENT LLC 02/14/2025 2.74 M $2.79 M   43.34% 1.32%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 2.27 M $2.32 M   100.00% 1.09%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 2.21 M $2.26 M   3.44% 1.06%
MORGAN STANLEY 02/14/2025 1.88 M $1.92 M   433.32% 0.90%
IKARIAN CAPITAL, LLC 02/14/2025 1.86 M $1.90 M   100.00% 0.89%
SCHONFELD STRATEGIC ADVISORS LLC 02/14/2025 1.71 M $1.74 M   100.00% 0.82%
GOLDMAN SACHS GROUP INC 02/11/2025 1.61 M $1.64 M   2,246.50% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.14 M $1.16 M   3.26% 0.55%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 1.06 M $1.08 M   57.22% 0.51%
TWO SIGMA INVESTMENTS, LP 02/14/2025 1.01 M $1.03 M   222.14% 0.49%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 832,200 $848,844   75.09% 0.40%
CITADEL ADVISORS LLC 02/14/2025 804,314 $820,400   10.63% 0.39%
HIGHTOWER ADVISORS, LLC 02/07/2025 756,823 $771,959   -4.57% 0.36%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/14/2025 742,462 $757,311   -49.55% 0.36%
ACUTA CAPITAL PARTNERS, LLC 02/14/2025 740,000 $754,800   100.00% 0.36%
SQUAREPOINT OPS LLC 02/14/2025 710,363 $724,570   100.00% 0.34%
TWO SIGMA ADVISERS, LP 02/14/2025 707,555 $721,706   100.00% 0.34%
CITADEL ADVISORS LLC 02/14/2025 608,200 $620,364   51.48% 0.29%
FMR LLC 02/13/2025 578,265 $589,830   6.30% 0.28%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 537,219 $547,963   100.00% 0.26%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 456,946 $466,085   100.00% 0.22%
MACQUARIE GROUP LTD 02/14/2025 400,000 $408,000   0.00% 0.19%
NORTHERN TRUST CORP 02/14/2025 398,289 $406,255   4.47% 0.19%
RAFFERTY ASSET MANAGEMENT, LLC 02/14/2025 351,337 $358,364   100.00% 0.17%
MARSHALL WACE, LLP 02/13/2025 337,130 $343,873   -85.68% 0.16%
UBS GROUP AG 02/14/2025 334,161 $340,844   240.39% 0.16%
BANK OF AMERICA CORP /DE/ 02/14/2025 331,256 $337,881   179.26% 0.16%
MILLENNIUM MANAGEMENT LLC 02/14/2025 329,400 $335,988   100.00% 0.16%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 328,064 $352,977   100.00% 0.16%
GOLDEN STATE EQUITY PARTNERS 01/24/2025 325,684 $332,198   2,592.27% 0.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 284,913 $290,611   -27.47% 0.14%
INVESCO LTD. 02/13/2025 264,641 $269,934   -11.25% 0.13%
EAM INVESTORS, LLC 02/13/2025 250,789 $255,805   100.00% 0.12%
GROUP ONE TRADING, L.P. 02/14/2025 202,881 $206,939   -47.00% 0.10%
SIMPLEX TRADING, LLC 02/11/2025 192,538 $196,000   67.81% 0.09%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 165,367 $168,674   100.00% 0.08%
CITIGROUP INC 02/12/2025 154,886 $157,984   4,681.91% 0.07%
JANE STREET GROUP, LLC 02/14/2025 152,933 $155,992   -52.78% 0.07%
VONTOBEL HOLDING LTD. 01/30/2025 152,100 $155,142   -49.30% 0.07%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 136,687 $139,421   100.00% 0.07%
CITADEL ADVISORS LLC 02/14/2025 131,300 $133,926   160.52% 0.06%
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 02/12/2025 124,037 $161,248   100.00% 0.06%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 03/17/2025 122,463 $124,912   12.41% 0.06%
OMERS ADMINISTRATION CORP 02/14/2025 107,300 $109,446   100.00% 0.05%
AMERICAN CENTURY COMPANIES INC 02/11/2025 105,337 $107,444   100.00% 0.05%

Sangamo Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 216 institutional investors and hedge funds held shares of Sangamo Therapeutics, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 9.37 M

WASATCH ADVISORS LP: 9.23 M

BlackRock, Inc.: 5.19 M

STATE STREET CORP: 5.02 M

RENAISSANCE TECHNOLOGIES LLC: 3.08 M

MILLENNIUM MANAGEMENT LLC: 2.74 M

29.52% of Sangamo Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 79.25 M shares in the last 24 months. This purchase volume represents approximately $48.34 M in transactions.